|
시장보고서
상품코드
1609701
일본의 지혈제 시장 보고서 : 제품, 제형, 용도, 지역별 지혈제 시장 보고서(2025-2033년)Japan Hemostats Market Report by Product, Formulation, Application, and Region 2025-2033 |
||||||
일본의 지혈제 시장 규모는 2024년 2억 2,030만 달러로 추정됩니다. 향후 IMARC Group은 2033년까지 시장이 3억 6,260만 달러에 도달하여 2025년부터 2033년까지 5.1%의 연평균 성장률(CAGR)을 보일 것으로 예상하고 있습니다. 심혈관 질환, 암, 당뇨병과 같은 만성 질환의 유병률 증가와 외과적 개입의 필요성 증가가 시장을 주도하고 있습니다.
본 보고서에서 다룬 주요 질문
- 일본 지혈제 시장은 지금까지 어떻게 성장해왔고 앞으로 어떻게 발전할 것인가?
- 코로나19가 일본 지혈제 시장에 미치는 영향은?
- 일본 지혈제 시장 제품별 분석은?
- 일본 지혈제 시장 제형별 분석은?
- 일본 지혈제 시장의 용도에 따른 분류는?
- 일본 지혈제 시장의 밸류체인에는 어떤 단계가 있는가?
- 일본 지혈제의 주요 촉진요인과 과제는?
- 일본 지혈제 시장 구조와 주요 업체는?
- 일본 지혈제 시장에서의 경쟁은 어느 정도인가?
목차
제1장 서문
제2장 조사 범위와 조사 방법
- 조사 목적
- 이해관계자
- 데이터 소스
- 시장 추정
- 조사 방법
제3장 주요 요약
제4장 일본의 지혈제 시장 : 서론
- 개요
- 시장 역학
- 업계 동향
- 경쟁 정보
제5장 일본의 지혈제 시장 구도
- 과거 및 현재 시장 동향(2019-2024년)
- 시장 예측(2025-2033년)
제6장 일본의 지혈제 시장 : 제품별 분석
- 트롬빈 기반
- 병용 기반
- 산화 재생 셀룰로오스 기반
- 젤라틴 기반
- 콜라겐 기반
제7장 일본의 지혈제 시장 : 제형별 분석
- 매트릭스 및 겔 지혈제
- 시트 및 패드 지혈제
- 스펀지 지혈제
- 분말 지혈제
제8장 일본의 지혈제 시장 : 용도별 분석
- 정형외과
- 일반외과
- 신경외과
- 심장혈관외과
- 재건 수술
- 부인과 수술
- 기타
제9장 일본의 지혈제 시장 : 경쟁 구도
- 개요
- 시장 구조
- 시장 기업 포지셔닝
- 주요 성공 전략
- 경쟁 대시보드
- 기업 평가 상한
제10장 주요 기업 개요
제11장 일본의 지혈제 시장 : 업계 분석
- 성장 촉진요인 및 억제요인과 기회
- Porter의 Five Forces 분석
- 밸류체인 분석
제12장 부록
LSH 24.12.23Japan hemostats market size reached USD 220.3 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 362.6 Million by 2033, exhibiting a growth rate (CAGR) of 5.1% during 2025-2033. The escalating prevalence of chronic diseases such as cardiovascular diseases, cancer, and diabetes, along with the rising need for surgical interventions, is driving the market.
Hemostats are surgical instruments used to control bleeding during medical procedures. They consist of two hinged, scissor-like handles with serrated jaws at the working end. These jaws can be locked in place to grip blood vessels or tissues, effectively clamping them shut to prevent further bleeding. Hemostats are commonly used in surgeries, both minor and major, as well as in various medical settings like emergency rooms and dental offices. The key function of hemostats is to provide precise and temporary occlusion of blood vessels, allowing healthcare professionals to work safely and effectively without excessive bleeding hindering their procedures. They come in various sizes and designs, with straight or curved tips, to accommodate different surgical needs. Hemostats can also be used to grasp and manipulate delicate tissues during surgery. Their versatility makes them invaluable tools in the medical field, aiding in achieving hemostasis and ensuring successful surgical outcomes while minimizing the risk of complications due to excessive bleeding.
Japan Hemostats Market Trends:
Several key factors are driving growth in the hemostats market. Firstly, the increasing number of surgical procedures in Japan has created a robust demand for hemostatic agents. As surgeries become more advanced and minimally invasive, the need for effective hemostats to control bleeding during these procedures has surged. Furthermore, the aging population is contributing significantly to market expansion. With a growing elderly demographic, the incidence of chronic diseases and surgeries, such as cardiovascular and orthopedic procedures, has risen, further propelling the demand for hemostatic products. Additionally, advancements in hemostatic technologies have played a pivotal role in market expansion. Innovative products with enhanced efficacy and safety profiles have gained traction among healthcare professionals, driving market growth. Furthermore, the increasing awareness of hemostatic products and their benefits among both healthcare providers and patients has positively influenced market dynamics. Moreover, the market is witnessing a surge in investment in R&D activities, fostering the introduction of novel hemostatic solutions. Collaborations between pharmaceutical companies and research institutions are pushing the boundaries of innovation, creating new opportunities in the hemostats market. These interconnected drivers are fueling the regional hemostats market's continued growth and are expected to shape its trajectory in the coming years.
Japan Hemostats Market Segmentation:
Product Insights:
- Thrombin Based
- Combination Based
- Oxidized Regenerated Cellulose Based
- Gelatin Based
- Collagen Based
Formulation Insights:
- Matrix and Gel Hemostats
- Sheet and Pad Hemostats
- Sponge Hemostats
- Powder Hemostats
Application Insights:
- Orthopedic Surgery
- General Surgery
- Neurological Surgery
- Cardiovascular Surgery
- Reconstructive Surgery
- Gynecological Surgery
- Others
Competitive Landscape:
The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
Key Questions Answered in This Report:
- How has the Japan hemostats market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the Japan hemostats market?
- What is the breakup of the Japan hemostats market on the basis of product?
- What is the breakup of the Japan hemostats market on the basis of formulation?
- What is the breakup of the Japan hemostats market on the basis of application?
- What are the various stages in the value chain of the Japan hemostats market?
- What are the key driving factors and challenges in the Japan hemostats?
- What is the structure of the Japan hemostats market and who are the key players?
- What is the degree of competition in the Japan hemostats market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Japan Hemostats Market - Introduction
- 4.1 Overview
- 4.2 Market Dynamics
- 4.3 Industry Trends
- 4.4 Competitive Intelligence
5 Japan Hemostats Market Landscape
- 5.1 Historical and Current Market Trends (2019-2024)
- 5.2 Market Forecast (2025-2033)
6 Japan Hemostats Market - Breakup by Product
- 6.1 Thrombin Based
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2019-2024)
- 6.1.3 Market Forecast (2025-2033)
- 6.2 Combination Based
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2019-2024)
- 6.2.3 Market Forecast (2025-2033)
- 6.3 Oxidized Regenerated Cellulose Based
- 6.3.1 Overview
- 6.3.2 Historical and Current Market Trends (2019-2024)
- 6.3.3 Market Forecast (2025-2033)
- 6.4 Gelatin Based
- 6.4.1 Overview
- 6.4.2 Historical and Current Market Trends (2019-2024)
- 6.4.3 Market Forecast (2025-2033)
- 6.5 Collagen Based
- 6.5.1 Overview
- 6.5.2 Historical and Current Market Trends (2019-2024)
- 6.5.3 Market Forecast (2025-2033)
7 Japan Hemostats Market - Breakup by Formulation
- 7.1 Matrix and Gel Hemostats
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2019-2024)
- 7.1.3 Market Forecast (2025-2033)
- 7.2 Sheet and Pad Hemostats
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2019-2024)
- 7.2.3 Market Forecast (2025-2033)
- 7.3 Sponge Hemostats
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2019-2024)
- 7.3.3 Market Forecast (2025-2033)
- 7.4 Powder Hemostats
- 7.4.1 Overview
- 7.4.2 Historical and Current Market Trends (2019-2024)
- 7.4.3 Market Forecast (2025-2033)
8 Japan Hemostats Market - Breakup by Application
- 8.1 Orthopedic Surgery
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2019-2024)
- 8.1.3 Market Forecast (2025-2033)
- 8.2 General Surgery
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2019-2024)
- 8.2.3 Market Forecast (2025-2033)
- 8.3 Neurological Surgery
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2019-2024)
- 8.3.3 Market Forecast (2025-2033)
- 8.4 Cardiovascular Surgery
- 8.4.1 Overview
- 8.4.2 Historical and Current Market Trends (2019-2024)
- 8.4.3 Market Forecast (2025-2033)
- 8.5 Reconstructive Surgery
- 8.5.1 Overview
- 8.5.2 Historical and Current Market Trends (2019-2024)
- 8.5.3 Market Forecast (2025-2033)
- 8.6 Gynecological Surgery
- 8.6.1 Overview
- 8.6.2 Historical and Current Market Trends (2019-2024)
- 8.6.3 Market Forecast (2025-2033)
- 8.7 Others
- 8.7.1 Historical and Current Market Trends (2019-2024)
- 8.7.2 Market Forecast (2025-2033)
9 Japan Hemostats Market - Competitive Landscape
- 9.1 Overview
- 9.2 Market Structure
- 9.3 Market Player Positioning
- 9.4 Top Winning Strategies
- 9.5 Competitive Dashboard
- 9.6 Company Evaluation Quadrant
10 Profiles of Key Players
- 10.1 Company A
- 10.1.1 Business Overview
- 10.1.2 Product Portfolio
- 10.1.3 Business Strategies
- 10.1.4 SWOT Analysis
- 10.1.5 Major News and Events
- 10.2 Company B
- 10.2.1 Business Overview
- 10.2.2 Product Portfolio
- 10.2.3 Business Strategies
- 10.2.4 SWOT Analysis
- 10.2.5 Major News and Events
- 10.3 Company C
- 10.3.1 Business Overview
- 10.3.2 Product Portfolio
- 10.3.3 Business Strategies
- 10.3.4 SWOT Analysis
- 10.3.5 Major News and Events
- 10.4 Company D
- 10.4.1 Business Overview
- 10.4.2 Product Portfolio
- 10.4.3 Business Strategies
- 10.4.4 SWOT Analysis
- 10.4.5 Major News and Events
- 10.5 Company E
- 10.5.1 Business Overview
- 10.5.2 Product Portfolio
- 10.5.3 Business Strategies
- 10.5.4 SWOT Analysis
- 10.5.5 Major News and Events
11 Japan Hemostats Market - Industry Analysis
- 11.1 Drivers, Restraints, and Opportunities
- 11.1.1 Overview
- 11.1.2 Drivers
- 11.1.3 Restraints
- 11.1.4 Opportunities
- 11.2 Porters Five Forces Analysis
- 11.2.1 Overview
- 11.2.2 Bargaining Power of Buyers
- 11.2.3 Bargaining Power of Suppliers
- 11.2.4 Degree of Competition
- 11.2.5 Threat of New Entrants
- 11.2.6 Threat of Substitutes
- 11.3 Value Chain Analysis
